Indoco Remedies receives accreditation from Japanese regulator
Indoco Remedies receives accreditation from Japanese regulator

Indoco Remedies receives accreditation from Japanese regulator

Tanay Loya Article rating: 5.0

Indoco Remedies witnessed a rise of 4 per cent in its share price during the morning hour. The company announced that its Patalganga unit has received accreditation from the Japanese drug regulatory authority.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 5.0

The markets on April 5, 2018 opened gap up. BSE Sensex is trading at 33,467.70, up by 448.63 points and the Nifty is trading at 10,277.25, up by 148.85 points. 

Past returns not a measure to evaluate scheme performance
Past returns not a measure to evaluate scheme performance

Past returns not a measure to evaluate scheme performance

DSIJ Intelligence Article rating: 5.0

Many times investors use the past returns record of a scheme to arrive at an investment decision. These past returns play a key role in determining the efficiency of the scheme and the fund manager.

RSS
First38193820382138223824382638273828Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR